Literature DB >> 19251439

Discrimination among IgG1-kappa monoclonal antibodies produced by two cell lines using charge state distributions in nanoESI-TOF mass spectra.

Leila Zamani1, Jessica Lindholm, Leopold L Ilag, Sven P Jacobsson.   

Abstract

Charge state distributions (CSDs) of proteins in nanoESI mass spectra are affected by the instrumental settings and experimental conditions, in addition to the conformations of the proteins in the analyzed solutions. In the presented study, instrumental and experimental parameters--the desolvation gas flow rate, temperature, pH, buffer (ammonium acetate), and organic modifier (methanol) concentrations--were optimized according to a reduced central composite face experimental design to maximize the separation of CSDs of monoclonal IgG1-kappa antibodies produced by two production systems (CHO and GS-NS0 cell lines). Principal component analysis and Fisher linear discriminant analysis were then used to reduce the dimensions of the acquired dataset and quantify the separation of the protein classes, respectively. The results show that the IgG1-kappa molecules produced by the two production systems can be clearly distinguished using the described approach, which could be readily applied to other proteins and production systems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19251439     DOI: 10.1016/j.jasms.2009.01.008

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  15 in total

1.  Detecting equilibrium cytochrome c folding intermediates by electrospray ionisation mass spectrometry: two partially folded forms populate the molten-globule state.

Authors:  Rita Grandori
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

Review 2.  Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals.

Authors:  Michael Butler
Journal:  Appl Microbiol Biotechnol       Date:  2005-04-16       Impact factor: 4.813

3.  Mass measurements of increased accuracy resolve heterogeneous populations of intact ribosomes.

Authors:  Adam R McKay; Brandon T Ruotolo; Leopold L Ilag; Carol V Robinson
Journal:  J Am Chem Soc       Date:  2006-09-06       Impact factor: 15.419

Review 4.  Post-translational modifications in the context of therapeutic proteins.

Authors:  Gary Walsh; Roy Jefferis
Journal:  Nat Biotechnol       Date:  2006-10       Impact factor: 54.908

Review 5.  The role of mass spectrometry in structure elucidation of dynamic protein complexes.

Authors:  Michal Sharon; Carol V Robinson
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

6.  Do ionic charges in ESI MS provide useful information on macromolecular structure?

Authors:  Igor A Kaltashov; Rinat R Abzalimov
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-03       Impact factor: 3.109

7.  Analytical properties of the nanoelectrospray ion source.

Authors:  M Wilm; M Mann
Journal:  Anal Chem       Date:  1996-01-01       Impact factor: 6.986

8.  Interpreting conformational effects in protein nano-ESI-MS spectra.

Authors:  Maria Samalikova; Irena Matecko; Norbert Müller; Rita Grandori
Journal:  Anal Bioanal Chem       Date:  2003-12-09       Impact factor: 4.142

9.  Unfolding of proteins monitored by electrospray ionization mass spectrometry: a comparison of positive and negative ion modes.

Authors:  L Konermann; D J Douglas
Journal:  J Am Soc Mass Spectrom       Date:  1998-12       Impact factor: 3.109

10.  Protein charge-state distributions in electrospray-ionization mass spectrometry do not appear to be limited by the surface tension of the solvent.

Authors:  Maria Samalikova; Rita Grandori
Journal:  J Am Chem Soc       Date:  2003-11-05       Impact factor: 15.419

View more
  5 in total

Review 1.  Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Guanbo Wang; Burcu Baykal; Shunhai Wang
Journal:  Biotechnol Adv       Date:  2011-05-17       Impact factor: 14.227

2.  Conformation and dynamics of biopharmaceuticals: transition of mass spectrometry-based tools from academe to industry.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Steven A Berkowitz; Damian Houde
Journal:  J Am Soc Mass Spectrom       Date:  2009-10-29       Impact factor: 3.109

Review 3.  Mass spectrometry for the biophysical characterization of therapeutic monoclonal antibodies.

Authors:  Hao Zhang; Weidong Cui; Michael L Gross
Journal:  FEBS Lett       Date:  2013-11-26       Impact factor: 4.124

Review 4.  Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars.

Authors:  Steven A Berkowitz; John R Engen; Jeffrey R Mazzeo; Graham B Jones
Journal:  Nat Rev Drug Discov       Date:  2012-06-29       Impact factor: 84.694

5.  A novel approach for the simultaneous quantification of a therapeutic monoclonal antibody in serum produced from two distinct host cell lines.

Authors:  Brian J Geist; Darryl Davis; Thomas McIntosh; Tong-Yuan Yang; Kenneth Goldberg; Chao Han; Charles Pendley; Hugh M Davis
Journal:  MAbs       Date:  2012-11-26       Impact factor: 5.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.